Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes

Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes

Hypogammaglobulinemia is a known side effect of rituximab (RTX) in adults, but its prevalence and persistence in children remain underexplored. This retrospective cohort study at a tertiary care center examines the prevalence and clinical outcomes of hypogammaglobulinemia in pediatric patients after...

Full description

Saved in:
Bibliographic Details
Main Authors: Susanna P.C. Höppener, Saskia R. Veldkamp, Mark C.H. de Groot, Saskia Haitjema, Julia Drylewicz, Jaap Jan Boelens, Caroline A. Lindemans, Joris van Montfrans, Annet van Royen-Kerkhof, Marc H.A. Jansen
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Clinical Immunology Communications
Subjects:
Hypogammaglobulinemia
Rituximab
Pediatric
B cell reconstitution
Online Access:http://www.sciencedirect.com/science/article/pii/S2772613425000046
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772613425000046

Similar Items